Cite Filings / ALGS / 0001193125-22-129730

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Aligos Therapeutics, Inc. Filed 2022-04-29 Acc 0001193125-22-129730

Documents 1

DEF 14A Proxy Statement , d278983ddef14a.htm

Around this filing

2023-04-28 DEF 14A Proxy Statement
2022-05-06 3 Initial Statement of Ownership
2022-05-04 8-K Results of operations
2022-05-04 10-Q Quarterly Report
2022-04-29 DEFA14A Proxy Materials
2022-04-29 DEF 14A Proxy Statement
2021-04-27 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d278983ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…